Publisher
Springer Science and Business Media LLC
Subject
Psychiatry and Mental health,Public Health, Environmental and Occupational Health,Health (social science)
Reference73 articles.
1. Aggarwal, N. K., Rosenheck, R. A., Woods, S. W., & Sernyak, M. J. (2012). Race and long-acting antipsychotic prescription at a community mental health center: A retrospective chart review. The Journal of Clinical Psychiatry, 73(4), 513–517.
2. American Diabetes Association, American Psychiatric Association, American Association of Clinical Endocrinologists, & North American Association for the Study of Obesity. (2004). Consensus development conference on antipsychotic drugs and obesity and diabetes. Diabetes Care, 27(2), 596–601.
3. Anil Yagcioglu, A. E., Kivircik Akdede, B. B., Turgut, T. I., Tumuklu, M., Yazici, M. K., Alptekin, K.,.. ., & Meltzer, H. Y. (2005). A double-blind controlled study of adjunctive treatment with risperidone in schizophrenic patients partially responsive to clozapine: Efficacy and safety. The Journal of Clinical Psychiatry, 66(1), 63–72.
4. Baandrup, L., Allerup, P., Lublin, H., Nordentoft, M., Peacock, L., & Glenthoj, B. (2010). Evaluation of a multifaceted intervention to limit excessive antipsychotic co-prescribing in schizophrenia out-patients. Acta Psychiatrica Scandinavica, 122(5), 367–374.
5. Becker, E. R., Constantine, R. J., McPherson, M. A., & Jones, M. E. (2013). Antipsychotic polypharmacy prescribing patterns and costs in the Florida adult and child Medicaid populations. Journal of Health Care Finance, 40(1), 40–67.
Cited by
9 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献